Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
Want to see RNAC full AI Analyst Report?
Cartesian Therapeutics (RNAC) Ownership Overview
48.96% Insiders
8.01% Mutual Funds
0.04% Other Institutional Investors
3.21% ETFs
39.78% Public Companies and
Individual Investors
The ownership structure of Cartesian Therapeutics (RNAC) stock is a mix of institutional, retail, and individual investors. Approximately 11.26% of the company’s stock is owned by Institutional Investors, 48.96% is owned by Insiders, and 39.78% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 08, 2026 | xxxxxxxxxxxxx | $161846 | |
Jan 08, 2026 | xxxxxxxxxxxxx | $24332 | |
Jan 08, 2026 | xxxxxxxxxxxxx | $72125 | |
Dec 08, 2025 | xxxxxxxxxxxxx | $205500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,820,260 | Insider | 21.96% | 39,286,755 | |
| 5,820,260 | Insider | 21.96% | 39,286,755 | |
| 704,446 | Insider | 2.66% | 4,755,011 | |
| 514,817 | Institution | 1.94% | 3,475,015 | |
| 455,767 | Institution | 1.72% | 3,076,427 | |
| 395,184 | Institution | 1.49% | 2,667,492 | |
| 366,554 | Institution | 1.38% | 2,474,240 | |
| 360,912 | Institution | 1.36% | 2,436,156 | |
| 323,530 | Insider | 1.22% | 2,183,828 | |
| 320,342 | Institution | 1.21% | 2,162,309 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 514,817 | Institution | 1.94% | 3,475,015 | |
| 395,184 | Institution | 1.49% | 2,667,492 | |
| 366,554 | Institution | 1.38% | 2,474,240 | |
| 320,342 | Institution | 1.21% | 2,162,309 | |
| 113,547 | Institution | 0.43% | 766,442 | |
| 104,908 | Institution | 0.40% | 708,129 | |
| 85,524 | Institution | 0.32% | 577,287 | |
| 59,130 | Institution | 0.22% | 399,128 | |
| 34,500 | Institution | 0.13% | 232,875 | |
| 25,000 | Institution | 0.09% | 168,750 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 280,909 | Institution | 1.06% | 1,727,590 | |
| 233,136 | Institution | 0.88% | 1,573,668 | |
| 114,275 | Institution | 0.43% | 702,791 | |
| 85,727 | Institution | 0.32% | 578,657 | |
| 51,745 | Institution | 0.20% | 318,232 | |
| 26,185 | Institution | 0.10% | 176,749 | |
| 15,864 | Institution | 0.06% | 107,082 | |
| 7,159 | Institution | 0.03% | 44,028 | |
| 4,920 | Institution | 0.02% | 34,292 | |
| 1,063 | Institution | <0.01% | 6,537 |
FAQ
Who Owns Cartesian Therapeutics (RNAC)?
According to the latest TipRanks data, approximately 0.04% of the company's stock is held by institutional investors, 48.96% is held by insiders, and 39.78% is held by retail investors.
What percentage of Cartesian Therapeutics (RNAC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.04% of Cartesian Therapeutics (RNAC) stock is held by institutional investors.
What percentage of Cartesian Therapeutics (RNAC) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.78% of Cartesian Therapeutics (RNAC) stock is held by retail investors.
Who owns the most shares of Cartesian Therapeutics (RNAC)?
Murat Kalayoglu owns the most shares of Cartesian Therapeutics (RNAC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.